RefleXion Medical announces major R&D milestones at ASTRO 2015

Company Completes Proof-of-Concept Prototype System and Collaborates With the University of Texas MD Anderson Cancer Center on Treatment Planning Study

HAYWARD, CA–(Marketwired – October 19, 2015) – RefleXion Medical, a privately held medical equipment company, announced today that it has completed a proof-of-concept prototype system and will be sharing key results at the 57th Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Antonio, TX.

RefleXion’s unique combination of PET imaging and external beam radiotherapy could improve tumor targeting, reduce toxicity and enable efficient treatment of multiple moving tumors in the body. Biologically-guided radiotherapy could also lead to transformative new clinical applications by leveraging novel PET radiotracers that probe different aspects of tumor biology.

“With the completion of a proof-of-concept system in under one year, we have mitigated all of the key technology risks in developing a combined PET-radiotherapy system,” said RefleXion President, Dr. Samuel Mazin. “We look forward to working with select research partners in bringing this technology into the clinic.”

RefleXion will also present results at ASTRO from a collaboration with The University of Texas MD Anderson Cancer Center. Dr. Jim Welsh, a physician-scientist at MD Anderson and RefleXion Scientific Advisor, mentioned, “The treatment planning studies completed by MD Anderson suggest that biologically-guided radiotherapy has significant potential in reducing toxicity to surrounding healthy tissue. This is one of several important new clinical applications that could be enabled by RefleXion’s technology.”

Monday October 19, 5:30PM – 6:45PM, Poster Viewing Reception

Dosimetric Comparison of Emission-Guided Radiation Therapy, Volumetric Modulated Arc Therapy, and Intensity-Modulated Proton Therapy for Thoracic Tumors

Steven N. Seyedin, Osama R. Mawlawi, Lehendrick M. Turner, Samuel R. Mazin, Yevgen Voronenko, Cody Adam Wages, Peter D. Olcott, Joe Y Chang, Daniel R. Gomez, Ritsuko U. Komaki, Peter A. Balter, and James W. Welsh